In the 4 eligible trials (the ABCD trial, the CAPPP, the FACET, and the UKPDS), the total number of participants was 2,180 (1,133 randomized to an ACE inhibitor and ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Diabetes is the leading cause of kidney failure ... other treatments for disease management such as medicines to manage blood ...

The following is a summary of “Differences between private and public primary health care centers and differences between men and women in antihypertensive care and cardiovascular prevention in all ...

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections and improve overall brain health.

Diabetes is the leading cause of kidney failure ... management such as medicines to manage blood pressure, including ACE inhibitors and ARBs. About 3,500 adults across 28 countries were enrolled ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, and hypertension. Pharmac ...